Septic shock drug trial halted early: Midodrine's promise unfulfilled
NCT ID NCT03706053
First seen Sep 30, 2025 · Last updated Jun 10, 2026 · Updated 30 times
Summary
This study tested whether the oral drug midodrine could help people with septic shock stop receiving IV blood pressure medications sooner. The trial aimed to enroll adults in the ICU with septic shock who needed a steady dose of norepinephrine. However, the study was stopped early after enrolling only 10 participants, so no clear conclusions can be drawn about midodrine's effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.